8-K
filed December 30, 2025, 6:59 PM ET
ticker TNDM
CIK 0001438133
other
confidence high
sentiment neutral
materiality 0.30
Tandem Diabetes amends bylaws with updated advance notice, proxy card, voting rules
TANDEM DIABETES CARE INC
- Board adopted Amended and Restated Bylaws on Dec 26, 2025 as part of periodic governance review.
- Advance notice provisions updated: stockholder nominees must satisfy Rule 14a-19 requirements; non-compliant nominees disregarded.
- White proxy card reserved exclusively for Board; other solicitations must use non-white cards.
- Voting standard (plurality for contested, majority for uncontested) determined 10 days before notice mailing.
- Board given express authority to cancel, reschedule, or postpone stockholder meetings.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001438133-25-000237
- form_type
- 8-K
- ticker
- TNDM
- cik
- 0001438133
- company_name
- TANDEM DIABETES CARE INC
- filed_at
- 2025-12-30T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:39.417280+00:00
- generated_at
- 2026-05-16T11:58:00.283848+00:00
- sec_items
- ["5.03", "9.01"]
- event_type
- other
- sentiment
- neutral
- materiality_score
- 0.3
- calibrated_materiality_score
- 0.3
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001438133-25-000237
- json_url
- https://secwatch.observer/filing/0001438133-25-000237.json
- markdown_url
- https://secwatch.observer/filing/0001438133-25-000237.md
- text_url
- https://secwatch.observer/filing/0001438133-25-000237.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1438133/000143813325000237/0001438133-25-000237-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1438133/000143813325000237/tndm-20251226.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SCHW
Charles Schwab files Certificate of Elimination for Series I Preferred Stock
SCHWAB CHARLES CORP
June 1, 2026, 5:00 PM ET
other
Items 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other
similar materiality
This filing
On December 26, 2025, in connection with a standard periodic review of the governance documents of Tandem Diabetes Care, Inc. (the “Company”), the Company’s board of directors (the “Board”) adopted Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), which became effective immediately and amended and restated the Company’s prior bylaws (the “Prior Bylaws”).
Comparable filing
On June 1, 2026, The Charles Schwab Corporation (the “Company”) filed a Certificate of Elimination with the Secretary of State of the State of Delaware with respect to the Company’s 4.000% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series I (“Series I Preferred Stock”), which, effective upon filing, eliminated from the Company’s Fifth Restated Certificate of Incorporation, as amended, all matters set forth in the Certificate of Designations for the Series I Preferred Stock.
Filing page
SEC filing
OPLN
OPENLANE eliminates Series A Convertible Preferred Stock from charter
OPENLANE, Inc.
May 29, 2026, 1:57 PM ET
other
Items 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other
similar materiality
This filing
On December 26, 2025, in connection with a standard periodic review of the governance documents of Tandem Diabetes Care, Inc. (the “Company”), the Company’s board of directors (the “Board”) adopted Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), which became effective immediately and amended and restated the Company’s prior bylaws (the “Prior Bylaws”).
Comparable filing
On May 29, 2026, OPENLANE, Inc. (the “Company”) filed a Certificate of Elimination (the “Certificate of Elimination”) with the Secretary of State of the State of Delaware effecting the elimination of the Certificate of Designations relating to the Company’s Series A Convertible Preferred Stock (the “Series A Preferred Stock”) previously filed by the Company with the Secretary of State of the State of Delaware on June 9, 2020.
Filing page
SEC filing
SCI
SCI shareholders approve board governance changes: director minimum cut to 3, board can fill vacancies
SERVICE CORP INTERNATIONAL
May 8, 2026, 7:59 PM ET
other
Items 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other
similar materiality
This filing
On December 26, 2025, in connection with a standard periodic review of the governance documents of Tandem Diabetes Care, Inc. (the “Company”), the Company’s board of directors (the “Board”) adopted Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), which became effective immediately and amended and restated the Company’s prior bylaws (the “Prior Bylaws”).
Comparable filing
The amendments to the Articles of Incorporation, which became effective on May 7, 2026, and the amendments to the Bylaws, which became effective on May 6, 2026 , include (i) changes permitting the Board to increase the number of directors and fill newly created vacancies, thereby eliminating restrictions requiring that newly created directorships be filled only by shareholders at an annual or special meeting, and (ii) changes reducing the minimum number of directors constituting the Board from nine to three directors (with the maximum remaining at fifteen directors).
Filing page
SEC filing
KGS
Kodiak shareholders approve board declassification and supermajority removal
Kodiak Gas Services, Inc.
May 7, 2026, 7:59 PM ET
other
Items 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other
similar materiality
This filing
On December 26, 2025, in connection with a standard periodic review of the governance documents of Tandem Diabetes Care, Inc. (the “Company”), the Company’s board of directors (the “Board”) adopted Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), which became effective immediately and amended and restated the Company’s prior bylaws (the “Prior Bylaws”).
Comparable filing
At the 2026 Annual Meeting of Shareholders (the “Annual Meeting”) of Kodiak Gas Services, Inc. (the “Company”) held on May 7, 2026, the Company’s shareholders approved certain amendments (the “Charter Amendments”) to the Company’s Amended and Restated Certificate of Incorporation (the “Charter”) to (i) phase in declassification of the Board of Directors (the “Board”) and (ii) eliminate certain supermajority voting requirements and other obsolete provisions.
Filing page
SEC filing
DAIO
Data I/O moves 2026 annual meeting to July 8; removes May meeting requirement
DATA I/O CORP
May 5, 2026, 7:59 PM ET
other
Items 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other
similar materiality
This filing
On December 26, 2025, in connection with a standard periodic review of the governance documents of Tandem Diabetes Care, Inc. (the “Company”), the Company’s board of directors (the “Board”) adopted Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), which became effective immediately and amended and restated the Company’s prior bylaws (the “Prior Bylaws”).
Comparable filing
On April 29, 2026, the Board of Directors (the “Board”) of Data I/O Corporation (the “Company”) adopted an amendment to the Bylaws of the Company (the “Bylaw Amendment”) which became effective immediately. The Bylaw Amendment modifies Article II Section (2) of the Company’s Bylaws to eliminate the requirement that the annual meeting of shareholders be held during the month of May.
Filing page
SEC filing
HSBC USA INC /MD/
HSBC USA amends bylaws to update officer titles and director appointment terms
HSBC USA INC /MD/
May 1, 2026, 7:59 PM ET
other
Items 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other
similar materiality
This filing
On December 26, 2025, in connection with a standard periodic review of the governance documents of Tandem Diabetes Care, Inc. (the “Company”), the Company’s board of directors (the “Board”) adopted Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), which became effective immediately and amended and restated the Company’s prior bylaws (the “Prior Bylaws”).
Comparable filing
On April 30, 2026 , the Board of Directors of HSBC USA Inc. (the "Board") approved an amendment to and a restatement of its bylaws (the "Bylaws"), which were effective immediately upon such approval by the Board.
Filing page
SEC filing
RNST
Renasant Corp. shareholders elect all 17 directors, approve executive compensation and auditor at 2026 annual meeting
RENASANT CORP
May 1, 2026, 7:59 PM ET
other
Items 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other
similar materiality
This filing
On December 26, 2025, in connection with a standard periodic review of the governance documents of Tandem Diabetes Care, Inc. (the “Company”), the Company’s board of directors (the “Board”) adopted Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), which became effective immediately and amended and restated the Company’s prior bylaws (the “Prior Bylaws”).
Comparable filing
On April 28, 2026, the Board of Directors (the “Board”) of Renasant Corporation (“Renasant”) approved and adopted Amended and Restated Bylaws of Renasant Corporation (the “Bylaws”), which became effective immediately.
Filing page
SEC filing
RVTY
Revvity shareholders approve bylaw amendment allowing 25% owners to call special meetings; all director nominees elected
REVVITY, INC.
May 1, 2026, 7:59 PM ET
other
Items 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other
similar materiality
This filing
On December 26, 2025, in connection with a standard periodic review of the governance documents of Tandem Diabetes Care, Inc. (the “Company”), the Company’s board of directors (the “Board”) adopted Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), which became effective immediately and amended and restated the Company’s prior bylaws (the “Prior Bylaws”).
Comparable filing
At the annual meeting of shareholders of Revvity, Inc. (the “Company”) held on April 28, 2026, the shareholders voted on and approved a proposal to amend the Company’s Amended and Restated By-laws (prior to such amendment and restatement, the “Prior By-laws”) to allow shareholders owning 25% of the Company’s stock to call a special meeting of shareholders (as amended and restated, the “Amended and Restated By-laws”) effective as of April 28, 2026.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.